Description
NSE reverses trading restrictions on SRPL and restores daily trading from weekly trading after the company paid overdue Annual Listing Fees for FY 2024-25.
Summary
NSE has reversed trading restrictions on Shree Ram Proteins Limited (SRPL) following the company’s payment of overdue Annual Listing Fees for Financial Year 2024-25. Trading will be restored from weekly trading series (BZ) to daily trading series (BZ) effective August 18, 2025.
Key Points
- SRPL has complied with Annual Listing Fees payment requirement for FY 2024-25
- Trading restrictions imposed in June and July 2025 are being reversed
- Company will move from weekly trading to daily trading in BZ series
- Action follows previous circulars NSE/CML/68677 (June 20, 2025) and NSE/CML/69208 (July 18, 2025)
Regulatory Changes
No regulatory changes - this is a reversal of previously imposed restrictions due to compliance by the company.
Compliance Requirements
SRPL has met the requirement of paying Annual Listing Fees for FY 2024-25, resolving the compliance issue that led to trading restrictions.
Important Dates
- Effective Date: August 18, 2025 - Trading restrictions lifted and daily trading restored
Impact Assessment
Minimal market impact as this affects only one company (SRPL). Positive development for SRPL shareholders as it restores normal daily trading liquidity from the restricted weekly trading format. Demonstrates the exchange’s systematic approach to enforcing and reversing compliance-related trading restrictions.
Impact Justification
Company-specific compliance resolution with minimal market impact